The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children

The Journal of Pediatrics
D ConnollyM Artman

Abstract

The assessment of the severity of heart failure in pediatric patients is handicapped by the subjectivity of diagnostic parameters. This study evaluated the feasibility of a new standardized heart failure index, the New York University Pediatric Heart Failure Index (NYU PHFI), to quantify the degree of heart failure in a selected pediatric population. The index is a weighted, linear combination of scores based on symptoms, physical signs, and medical regimen. Overall, healthy children (n = 12) scored very low (0 to 2) on this index. Mean scores of children (<2 years; mean age, 4.8 months; n = 12) with a left-to-right shunt lesion declined from 11.4 (SD +/- 4.1, P <.001, 2-tailed test) before surgery to 1.8 (SD +/- 1.3) after surgical correction of their cardiac defects. The average inter-observer correlation coefficient was 0.95 (P <.001), despite a wide range of scores. The NYU PHFI appears to be a reliable and convenient instrument for measuring heart failure severity in children. These initial results support further testing in broader diagnostic and age groups and over longer periods.

Citations

Aug 26, 2009·Cardiology in the Young·Armen KocharianGiv Heidari-Bateni
Oct 24, 2009·Cardiology in the Young·Armen KocharianNasrollah Hosseini-Navid
Apr 1, 2011·European Heart Journal·Annelies E van der HulstEduard R Holman
Jan 6, 2010·Pediatrics in Review·Erin Madriago, Michael Silberbach
Apr 15, 2014·Annals of the American Thoracic Society·Suhail Al-SalehIndra Narang
Oct 18, 2015·Pediatric Cardiology·Susanna L den BoerMichiel Dalinghaus
Dec 18, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Keiichi HironoFukiko Ichida
Dec 27, 2005·Expert Review of Cardiovascular Therapy·Hans Henrik Odland, Erik M D Thaulow
Oct 8, 2009·Circulation. Heart Failure·Daphne T Hsu, Gail D Pearson
Mar 18, 2017·Circulation Research·Robert B Hinton, Stephanie M Ware
Oct 8, 2009·Circulation. Heart Failure·Daphne T Hsu, Gail D Pearson
Sep 9, 2006·Neuropsychology Review·M MiattonG Vingerhoets
Feb 20, 2008·Intensive Care Medicine·Pierre TissièresMaurice Beghetti
Oct 2, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Tomohiro KitamuraMasahiko Kishiro
Feb 6, 2008·Expert Review of Cardiovascular Therapy·Renee Margossian
May 10, 2019·Journal of the American Heart Association·Anyir HsiehShabnam Peyvandi
May 12, 2009·BMC Health Services Research·Christiane MuthFerdinand M Gerlach
Mar 13, 2020·Indian Journal of Pediatrics·Manojkumar Rohit, Sudhansu Budakoty
Jun 9, 2004·European Journal of Heart Failure·Viviane M ConraadsChristiaan J Vrints
Sep 26, 2019·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Malindi van der MheenMichiel Dalinghaus
Jan 18, 2012·Current Opinion in Cardiology·Kathleen E Simpson, Charles E Canter
Oct 1, 2013·Current Heart Failure Reports·Manojkumar RohitK K Talwar
Dec 24, 2005·Pediatric Cardiology·J SoongswangC Kangkagate
May 28, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasunobu HayabuchiShoji Kagami
Apr 20, 2021·Pediatric Cardiology·Raysa Morales-DemoriSusan Denfield
Oct 4, 2021·Metabolomics : Official Journal of the Metabolomic Society·Thomas M O'ConnellR Mark Payne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Circulation Journal : Official Journal of the Japanese Circulation Society
Aya MiyazakiOsamu Yamada
Journal of Cardiothoracic and Vascular Anesthesia
P LaitinenJ Räsänen
Progress in Pediatric Cardiology
S LatifiJ L Blumer
JAMA : the Journal of the American Medical Association
Samuel S Gidding
© 2021 Meta ULC. All rights reserved